Colagrossi, L.; Salpini, R.; Scutari, R.; Carioti, L.; Battisti, A.; Piermatteo, L.; Bertoli, A.; Fabeni, L.; Minichini, C.; Trimoulet, P.;
et al. HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets. Viruses 2018, 10, 363.
https://doi.org/10.3390/v10070363
AMA Style
Colagrossi L, Salpini R, Scutari R, Carioti L, Battisti A, Piermatteo L, Bertoli A, Fabeni L, Minichini C, Trimoulet P,
et al. HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets. Viruses. 2018; 10(7):363.
https://doi.org/10.3390/v10070363
Chicago/Turabian Style
Colagrossi, Luna, Romina Salpini, Rossana Scutari, Luca Carioti, Arianna Battisti, Lorenzo Piermatteo, Ada Bertoli, Lavinia Fabeni, Carmine Minichini, Pascale Trimoulet,
and et al. 2018. "HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets" Viruses 10, no. 7: 363.
https://doi.org/10.3390/v10070363
APA Style
Colagrossi, L., Salpini, R., Scutari, R., Carioti, L., Battisti, A., Piermatteo, L., Bertoli, A., Fabeni, L., Minichini, C., Trimoulet, P., Fleury, H., Nebuloso, E., De Cristofaro, M., Cappiello, G., Spanò, A., Malagnino, V., Mari, T., Barlattani, A., Iapadre, N.,
... Svicher, V.
(2018). HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets. Viruses, 10(7), 363.
https://doi.org/10.3390/v10070363